Keywords: CLL، لوسمی لنفوسیتی مزمن; hMPV; Stem cell transplantation; Leukemia; Lymphoma; Cancer; MortalityALL, acute lymphoblastic leukemia; Allo-HCT, allogeneic HCT; AML, acute myeloid leukemia; auto-HCT, autologous HCT; CI, confidence interval; CLL, chronic lymphocytic leukemia; CML, chro
مقالات ISI CLL، لوسمی لنفوسیتی مزمن (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: CLL، لوسمی لنفوسیتی مزمن; ADCC, antibody-de-pendent cytotoxicity; ALM, alemtuzumab; CLL, chronic lymphocytic leukemia; CCP, complement control protein; CDC, complement-dependent cytotoxicity; MAC, membrane attack complex; NIP, 5-iodo-4-hydroxy-3-nitrophenacetyl; OFA, ofatumumab; r
Keywords: CLL، لوسمی لنفوسیتی مزمن; Cancer stem cells; Resistance; Chemotherapy; Cell signaling; Resistance; Lung cancerABC, ATP-binding cassette transporters; ALDH, aldehyde dehydrogenase; CD, cluster of differentiation; CLL, chronic lymphocytic leukemia; CSC, cancer stem cell; CSC-DC, can
Keywords: CLL، لوسمی لنفوسیتی مزمن; AIHA, autoimmune hemolytic anemia; APL, antiphospholipid antibodies; CLL, chronic lymphocytic leukemia; DVT, deep vein thrombosis; PE, pulmonary embolism; VTE, venous thromboembolism; wAIHA, warm autoimmune hemolytic anemiaAuto-immune hemolytic anemia; Ve
Keywords: CLL، لوسمی لنفوسیتی مزمن; chronic lymphocytic leukemia; immunosuppression; malignant melanoma; Mohs micrographic surgeryBCC, basal cell carcinoma; CI, confidence interval; CLL, chronic lymphocytic leukemia; NHL, non-Hodgkin lymphoma; NMSC, nonmelanoma skin cancer; REP, Rochester E
Keywords: CLL، لوسمی لنفوسیتی مزمن; ACIP, Advisory Committee on Immunization Practices; CDC, Center for Diseases Control; CMV, Cytomegalovirus; CLL, chronic lymphocytic leukemia; EBMT, European Group for Blood and Marrow Transplantation; GM-CSF, granulocyte-macrophage colony-stimulating fac
Keywords: CLL، لوسمی لنفوسیتی مزمن; AL, acute leukemia, not otherwise specified; ALL, acute lymphocytic leukemia; AML, acute myeloid leukemia; CI, confidence interval; CL, chronic leukemia, not otherwise specified; CLL, chronic lymphocytic leukemia; CML, chronic myeloid leukemia; F, female;
Keywords: CLL، لوسمی لنفوسیتی مزمن; AB, apico-basal polarity; AML, acute myeloid leukemia; CE, convergence extension; CLL, chronic lymphocytic leukemia; COPII, coat protein complex II; dpc, days post coïtum; Dvl, disheveled; ER, endoplasmic reticulum; Fz, frizzled receptor; JNK, jun kinase;
The ibrutinib B-cell proliferation inhibition is potentiated in vitro by dexamethasone: Application to chronic lymphocytic leukemia
Keywords: CLL، لوسمی لنفوسیتی مزمن; BCR, B-cell receptor; BTK, Bruton tyrosine kinase; CLL, chronic lymphocytic leukemia; DXM, dexamethasone; GR, glucocorticoid receptor; CDK, cyclin-dependant kinase; PBL, peripheral blood lymphocytes; ROS, reactive oxygen speciesLymphoid B-cells; Chronic l
An LC/MS/MS method for the simultaneous determination of individual sphingolipid species in B cells
Keywords: CLL، لوسمی لنفوسیتی مزمن; Cer, ceramide; CLL, Chronic Lymphocytic Leukemia; dHCer, dihydroceramide; ELSD, evaporating light scattering detector; ESI, electrospray ionization; FA, fatty acid; GlcCer, glucosylceramides; GSL, glycosphingolipid; HILIC, hydrophilic interaction chromato
Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma
Keywords: CLL، لوسمی لنفوسیتی مزمن; AF, Auranofin; AML, Acute myeloid leukemia; ANOVA, Analysis of variance; AP-1, Activator protein-1; ARE, Antioxidant response element; BM, Bone marrow; Btz, Bortezomib; CLL, Chronic lymphocytic leukemia; CML, Chronic myeloid leukemia; CuPP IX, Copper Prot
Comparison of chest-CT findings of Influenza virus-associated pneumonia in immunocompetent vs. immunocompromised patients
Keywords: CLL، لوسمی لنفوسیتی مزمن; AML, acute myelogenous leukemia; MM, multiple myeloma; MDS, myelodysplastic syndrome; NHL, non-Hodgkin lymphoma; CLL, chronic lymphocytic leukemia; ALL, acute lymphocytic leukemia; PRCA, pure red cell aplasia; CML, chronic myelogenous leukemia; PCNSL, pri
Moving targets: Emerging roles for MMPs in cancer progression and metastasis
Keywords: CLL، لوسمی لنفوسیتی مزمن; ABP, activity-based probe; BMDC, bone marrow-derived cells; CLL, chronic lymphocytic leukemia; ECM, extracellular matrix; EPR, enhanced permeability and retention; FITC, fluorescein isothiocyanate; HSP, heat shock protein; LOX, lysyl oxidase; MMP, matrix
Targeting PI3 kinase in cancer
Keywords: CLL، لوسمی لنفوسیتی مزمن; PI3K pathway; Isoforms; Review; PI3K inhibitors; PI3K/Akt/mTORAE, Adverse event; ALT, Alanine transaminase; AST, Aspartate transaminase; CLL, Chronic lymphocytic leukemia; DLT, Dose-limiting toxicity; FDA, Food and Drug Administration; GIST, Gastrointesti
Ikaros could be a key factor in the maintenance of “B-side” of B-1 cells
Keywords: CLL، لوسمی لنفوسیتی مزمن; CEDEME, Centro de Desenvolvimento de Modelos Experimentais para Medicina e Biologia da Universidade Federal de São Paulo; ChIP, chromatin immunoprecipitation; CLL, chronic lymphocytic leukemia; CLPs, commom lymphoid progenitor; FBS, fetal bovine serum; GF
Implication of B lymphocytes in the pathogenesis of ANCA-associated vasculitides
Keywords: CLL، لوسمی لنفوسیتی مزمن; Aa, amino acid; AAV, ANCA-associated vasculitides; ANCA, anti-neutrophil cytoplasm antibodies; BAFF, B-cell activated factor; BAFF-R, BAFF receptor; BCR, B-cell receptor; c-ANCA, cytoplasmic ANCA; CLL, chronic lymphocytic leukemia; CTLA-4, cytotoxic T lym
The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6
Keywords: CLL، لوسمی لنفوسیتی مزمن; CLL, chronic lymphocytic leukemia; BMSCs, bone marrow stromal cells; IL-6, interleukin-6; IL-1β, interleukin-1β; bFGF, basic fibroblast growth factor; SDF-1, stromal cell-derived factor-1; STAT3, signal transducer and activator of transcription 3; HDACs,
Integrated analysis of gene expression and microRNA regulation in three leukemia-related lymphoblastic cell lines
Keywords: CLL، لوسمی لنفوسیتی مزمن; ALL, acute lymphocytic leukemia; CLL, chronic lymphocytic leukemia; CLP, common lymphoid progenitor; EBV, Epstein–Barr virus; 3′-UTR, 3′ untranslated region; PCR, polymerase chain reaction; BIG, Beijing Institute of Genomics; CAS, Chinese Academy of Scien
Investigation of circulating lncRNAs in B-cell neoplasms
Keywords: CLL، لوسمی لنفوسیتی مزمن; CLL, Chronic Lymphocytic Leukemia; MM, Multiple Myeloma; LncRNA, Long non-coding RNA; TUG1, Taurine Up-regulated Gene 1; MALAT1, Metastasis Associated Lung Adenocarcinoma Transcript 1; HOTAIR, HOX Antisense Intergenic RNA; GAS5, Growth Arrest Specific 5;
GALNT11 as a new molecular marker in chronic lymphocytic leukemia
Keywords: CLL، لوسمی لنفوسیتی مزمن; aa, amino acid(s); bp, base pair; BSA, bovine serum albumin; CD19, cluster of differentiation 19; CD3, cluster of differentiation 3; cDNA, DNA complementary to RNA; CLL, chronic lymphocytic leukemia; FBS, fetal bovine serum; GalNAc-Ts, UDP-N-acetyl-α-d-ga
4-Amino-2-arylamino-6-(2,6-dichlorophenyl)-pyrido[2,3-d]pyrimidin-7-(8H)-ones as BCR kinase inhibitors for B lymphoid malignancies
Keywords: CLL، لوسمی لنفوسیتی مزمن; Non-Hodgkin's lymphomas; B-cell receptor; Kinases; Small molecule inhibitor; 7-oxopyrido[2,3-d]pyrimidinesAbl, Abelson; Bcl-2, B-cell lymphoma 2; BCR, B-cell receptor; Btk, Bruton's tyrosine kinase; CLL, chronic lymphocytic leukemia; DLBCL, diffuse large
A dual role for the anti-apoptotic Bcl-2 protein in cancer: Mitochondria versus endoplasmic reticulum
Keywords: CLL، لوسمی لنفوسیتی مزمن; ATP, adenosine triphosphate; BI-1, Bax inhibitor-1; BH, Bcl-2-homology; CN, calcineurin; CaM, calmodulin; CLL, chronic lymphocytic leukemia; JNK1, c-Jun N-terminal kinase 1; DLBCL, diffuse large B-cell lymphoma; DARPP-32, dopamine- and cAMP-regulated phos
Total expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patients
Keywords: CLL، لوسمی لنفوسیتی مزمن; CLL, chronic lymphocytic leukemia; MHC, major histocompatibility complex; NK, natural killer cells; DC, dendritic cells; Treg, regulatory T cells; TLRs, Toll-like receptors; PAMPs, pathogen-associated molecular patterns; TLR-9, Toll-like receptor 9; HV, h
Evaluation of tyrosine-kinase receptor c-KIT (c-KIT) mutations, mRNA and protein expression in canine leukemia: Might c-KIT represent a therapeutic target?
Keywords: CLL، لوسمی لنفوسیتی مزمن; AL, acute leukemia; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; AU, arbitrary units; AUL, acute undifferentiated leukemia; c-KIT, proto-oncogene c-KIT; CLL, chronic lymphocytic leukemia; CTRL, control; FLT3, fins-like tyrosine-kinase 3
ABT-737 resistance in B-cells isolated from chronic lymphocytic leukemia patients and leukemia cell lines is overcome by the pleiotropic kinase inhibitor quercetin through Mcl-1 down-regulation
Keywords: CLL، لوسمی لنفوسیتی مزمن; Bcl-2, B-cell lymphoma; BH3, Bcl-2 homology domain 3; CI, combination index; CLL, chronic lymphocytic leukemia; CR, complete remission; Mcl-1, myeloid cell leukemia 1; MEK, mitogen-activated protein kinase kinase; PI3K, phosphatidylinositol-3-kinase; PBMC
Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy
Keywords: CLL، لوسمی لنفوسیتی مزمن; AML, acute myeloid leukemia; bp, base pairs; CLL, chronic lymphocytic leukemia; CST, CTC1/STN1/TEN1; CTC1, conserved telomere maintenance component 1; DC, dyskeratosis congenita; FA, Fanconi anemia; FISH, fluorescence in situ hybridization; MDS, myelodysp
Altered Ca2 + signaling in cancer cells: Proto-oncogenes and tumor suppressors targeting IP3 receptors
Keywords: CLL، لوسمی لنفوسیتی مزمن; AMPK, AMP-dependent kinase; Bcl-2-2, B-cell lymphoma 2; Bcl-XL, B-cell lymphoma extra large; BI-1, Bax Inhibitor-1; CLL, chronic lymphocytic leukemia; DL-BCL, diffuse-large B-cell lymphoma; E2, 17β-estradiol; FoxO, Forkhead box O; GSL, glycosphingolipids;
Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy
Keywords: CLL، لوسمی لنفوسیتی مزمن; AIDS, acquired immunodeficiency disease syndrome; APC, antigen-presenting cell; CAG, cytomegalovirus beta-actin hybrid promoter; CAR, chimeric antigen receptor; CLL, chronic lymphocytic leukemia; CMV, cytomegalovirus; CRC, clinical research center; DGF, d
LBH-589 (panobinostat) potentiates fludarabine anti-leukemic activity through a JNK- and XIAP-dependent mechanism
Keywords: CLL، لوسمی لنفوسیتی مزمن; AML, acute myelogenous leukemia; CLL, chronic lymphocytic leukemia; CTCL, cutaneous T-cell lymphoma; LBH-589, panobinostat; FdA, fludarabine; HDACI, histone deacetylase inhibitor; XIAP, X chromosome-linked inhibitor of apoptosis; JNK, c-Jun N-terminal kin
Blinatumomab: A historical perspective
Keywords: CLL، لوسمی لنفوسیتی مزمن; AE, Adverse event; ALL, Acute lymphoblastic leukemia; BiTE®, Bispecific T cell Engager; CHO, Chinese hamster ovary; CLL, Chronic lymphocytic leukemia; CNS, Central nervous system; CR, Complete remission; DLBCL, Diffuse large B cell lymphoma; FL, Follicula
The application and biology of immunomodulatory drugs (IMiDs) in cancer
Keywords: CLL، لوسمی لنفوسیتی مزمن; AML, acute myeloid leukemia; ASCT, autologous stem cell transplant; CLL, chronic lymphocytic leukemia; CTD, cyclophosphamide-thalidomide-dexamethasone; CTDa-T, cyclophosphamide-thalidomide-dexamethasone followed by thalidomide maintenance; CVAD, cyclophos
Mammalian cell protein expression for biopharmaceutical production
Keywords: CLL، لوسمی لنفوسیتی مزمن; 6-TG, 6-thioguanine; ACE, Artificial Chromosome Expression; ADCC, Antibody-dependent Cellular Cytotoxicity; BGH, Bovine Growth Hormone; BHK, Baby Hamster Kidney; CHO, Chinese Hamster Ovary; CLL, Chronic Lymphocytic Leukemia; CMV, Cytomegalovirus; CTE, Con
The B-cell lymphoma 2 (BCL2)-inhibitors, ABT-737 and ABT-263, are substrates for P-glycoprotein
Keywords: CLL، لوسمی لنفوسیتی مزمن; BCL2; P-glycoprotein; Drug resistance; ABT-263 (Navitoclax); ABT-737ATP, binding cassette (ABC); BCL2, B-cell lymphoma 2; CLL, chronic lymphocytic leukemia
Phenotype-based drug screening in primary ovarian carcinoma cultures identifies intracellular iron depletion as a promising strategy for cancer treatment
Keywords: CLL، لوسمی لنفوسیتی مزمن; ALL, acute lymphocytic leukemia; AML, acute myelocytic leukemia; CLL, chronic lymphocytic leukemia; CML, chronic myelocytic leukemia; NHL, non-Hodgkin's lymphoma; PBMC, peripheral blood mononuclear cellsScreening; Ovarian cancer; Primary cultures; Iron de
MicroRNAs as therapeutic targets in cancer
Keywords: CLL، لوسمی لنفوسیتی مزمن; AMO, Anti-miRNA oligonucleotides; CLL, chronic lymphocytic leukemia; DLEU, deleted in leukemia; EMT, epithelial mesenchymal transition; HCC, hepatocellular carcinoma; IGF-1, insulin growth factor 1; IRS-1, insulin receptor substrate 1; LNA, locked nucleic
Small molecules with big effects: The role of the microRNAome in cancer and carcinogenesis
Keywords: CLL، لوسمی لنفوسیتی مزمن; miRNA, microRNA; AGO, argonaute; miRNP, miRNA/AGO ribonucleoprotein; RISC, RNA-induced silencing complex; MRE, miRNA recognition element; CLL, chronic lymphocytic leukemia; BCL2, B-cell lymphoma 2; oncomiR, oncogenic miRNA; HOXD10, homeobox protein D10; T
Does rituximab increase the incidence of infectious complications? A narrative review
Keywords: CLL، لوسمی لنفوسیتی مزمن; CHOP, cyclophosphamide doxorubicin vincristine and prednisone; CLL, chronic lymphocytic leukemia; CVP, cyclophosphamide, vincristine, and prednisone; CI, confidence intervals; CMV, cytomegalovirus; CNS, central nervous system; DLBCL, diffuse large B-cell
ABT-737 overcomes Bcl-2 mediated resistance to doxorubicin–DNA adducts
Keywords: CLL، لوسمی لنفوسیتی مزمن; AML, acute myelogenous leukemia; CDK, cyclin-dependent kinase; CLL, chronic lymphocytic leukemia; CPM, counts per minute; DTT, dithiothreitol; FACS, fluorescence-activated cell sorting; PEG, poly-ethylene glycol; SCLC, small-cell lung carcinoma; WT, wild-
The miR-15/107 Group of MicroRNA Genes: Evolutionary Biology, Cellular Functions, and Roles in Human Diseases
Keywords: CLL، لوسمی لنفوسیتی مزمن; miRNA, microRNA; PANK, pantothenate kinase; CoA, coenzyme A; TBI, traumatic brain injury; GRN, granulin; CLL, chronic lymphocytic leukemia; AD, Alzheimer's disease; PKAN, PANK-associated neurodegenerationmiR-107; miR-103; miR-16; brain; neurodegeneration
Personalized medicine: individualized care of cancer patients
Keywords: CLL، لوسمی لنفوسیتی مزمن; CLL, chronic lymphocytic leukemia; CML, chronic myelogenous leukemia; CR, complete remission; CT, cancer-testis; IHC, immunohistochemistry; MM, multiple myeloma; Rb, retinoblastoma protein
Increased Risk for Non-Hodgkin Lymphoma in Individuals With Celiac Disease and a Potential Familial Association
Keywords: CLL، لوسمی لنفوسیتی مزمن; CD, celiac disease; HL, Hodgkin lymphoma; HLA, human leukocytes antigen; NHL, non-Hodgkin lymphoma; OR, odds ratio; CLL, chronic lymphocytic leukemia
Unusual cutaneous manifestations of B-cell chronic lymphocytic leukemia
Keywords: CLL، لوسمی لنفوسیتی مزمن; B-cell chronic lymphocytic leukemia; leukemic infiltration; lymphoid leukemia; lymphoproliferative disordersB-CLL, B-cell chronic lymphocytic leukemia; CLL, chronic lymphocytic leukemia; ICAM-1, intercellular adhesion molecule-1; LFA-1, lymphocyte functio
Mechanisms of anti-cancer action and pharmacology of clofarabine
Keywords: CLL، لوسمی لنفوسیتی مزمن; ADA, adenosine deaminase; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; AraC, cytarabine; CAFdA, clofarabine; CdA, cladribine; CLL, chronic lymphocytic leukemia; dCK, deoxycytidine kinase; dGK, deoxyguanosine kinase; DLT, dose-limiting t
DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1
Keywords: CLL، لوسمی لنفوسیتی مزمن; CLL, chronic lymphocytic leukemia; DLEU2, deleted in lymphocytic leukemia 2; MDR, minimally deleted regionChronic lymphocytic leukemia; Cyclins; Host gene; miR-15a; miR-16-1; Myc
Circulating endothelial cells, bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer: From biology to therapy
Keywords: CLL، لوسمی لنفوسیتی مزمن; αSMA, α-smooth muscle actin; AML, acute myeloid leukemia; Ang-1, angiopoietin-1; BM, bone marrow; CAC, circulating angiogenic cell; CEC, circulating endothelial cell; CFU-EC, colony-forming unit-endothelial cells; CLL, chronic lymphocytic leukemia; CRP, C
Variations in presentation of squamous cell carcinoma in situ (Bowen's disease) in immunocompromised patients
Keywords: CLL، لوسمی لنفوسیتی مزمن; CLL, chronic lymphocytic leukemia; NMSC, nonmelanoma skin cancer; OTR, organ transplant recipient; SCC, squamous cell carcinoma
Analysis of sequence variations in 59 microRNAs in hepatocellular carcinomas
Keywords: CLL، لوسمی لنفوسیتی مزمن; CLL, chronic lymphocytic leukemia; HCC, hepatocellular carcinoma; miRNA(s), MicroRNA(s); PCR-SSCA, PCR-based single-strand conformational analysis; pre-miRNA, microRNA precursor; SNPs, single nucleotide polymorphisms; HBV, hepatitis B virusMicroRNA; Seque
Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features
Keywords: CLL، لوسمی لنفوسیتی مزمن; AEIOU, asymptomatic/lack of tenderness, expanding rapidly, immune suppression, older than 50 years, ultraviolet-exposed/fair skin; CLL, chronic lymphocytic leukemia; MCC, Merkel cell carcinoma; SEER, Surveillance, Epidemiology, and End Results; UV, ultrav
BCL11B is a general transcriptional repressor of the HIV-1 long terminal repeat in T lymphocytes through recruitment of the NuRD complex
Keywords: CLL، لوسمی لنفوسیتی مزمن; BCL11B, B-cell CLL/lymphoma 11B; CLL, chronic lymphocytic leukemia; ChIP, chromatin immunoprecipitation; EMSA, electrophoretic mobility shift assay; HDAC, histone deacetylase complex; HIV-1, human immunodeficiency virus 1; LTR, long terminal repeat; NuRD,
Not miR-ly small RNAs: Big potential for microRNAs in therapy
Keywords: CLL، لوسمی لنفوسیتی مزمن; RNA interference; small interfering RNA; microRNA; antagomiRAMD, Age-related macular degeneration; CLL, Chronic lymphocytic leukemia; CPP, Cell-penetrating peptide; dsRNA, Double-strand RNA; HBV, Hepatitis B virus; miRNA, MicroRNA; RISC, RNA-induced silen